Faruqi & Faruqi, LLP, and Kaplan Fox & Kilsheimer LLP remind Hims & Hers Health, Inc. investors of a November 2, 2026 deadline. This deadline is for investors to seek lead plaintiff status in a federal securities class-action lawsuit. The lawsuit alleges Hims & Hers made materially false and misleading statements. These statements concern its privacy practices and billing procedures.
The Federal Trade Commission (FTC) filed a lawsuit on July 29, 2026. The FTC alleged Hims & Hers shared sensitive consumer health information with third-party advertising platforms. It also alleged the company engaged in deceptive billing and cancellation practices. Hims' stock price fell significantly after the FTC's announcement.